Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by made2laston Aug 31, 2018 10:37am

86 Views

Post# 28548463

RE:American Bladder Cancer Society were not aware of PDT

Hi bencro;

Aside from the investment aspect of your efforts, thank you, and all others for taking the initiative to inform the folks that can help accelerate this technology into the market. Theralase technologies will help the many people and animals that are suffering from cancer, and other ailments and disease.

Thanks;

made2last

bencro wrote: American Bladder Cancer Society has also been informed of TLT's results and that sounded like out of nowhere from them. They were not aware of PDT either. They agreed to look at it more closely.

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages